Mobirise themes are based on Bootstrap 3 and Bootstrap 4 - most powerful mobile first framework. Now, even if you're not code-savvy, you can be a part of an exciting growing bootstrap community.
Choose from the large selection of latest pre-made blocks - full-screen intro, bootstrap carousel, content slider, responsive image gallery with lightbox, parallax scrolling, video backgrounds, hamburger menu, sticky header and more.
Sites made with Mobirise are 100% mobile-friendly according the latest Google Test and Google loves those websites (officially)!
Mobirise themes are based on Bootstrap 3 and Bootstrap 4 - most powerful mobile first framework. Now, even if you're not code-savvy, you can be a part of an exciting growing bootstrap community.
Choose from the large selection of latest pre-made blocks - full-screen intro, bootstrap carousel, content slider, responsive image gallery with lightbox, parallax scrolling, video backgrounds, hamburger menu, sticky header and more.
Due to outstanding quality of research and the scientific accomplishments, the center stands out to be one of the pioneering gene and cell therapy research facilities in the country...
Glybera is indicated for adult patients diagnosed with familial lipoprotein lipase deficiency (LPLD) and suffering from severe or multiple pancreatitis attacks despite dietary fat restrictions. The diagnosis of LPLD has to be confirmed by genetic testing. The indication is restricted to patients with detectable levels of LPL protein.
Read more
Strimvelis is a medicine used to treat severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID). ADA-SCID is a rare inherited condition in which there is a change (mutation) in the gene needed to make an enzyme called adenosine deaminase (ADA).
Read more
Imlygic is a cancer medicine used to treat adults with melanoma (a type of skin cancer) that cannot be surgically removed and that has spread to other parts of the body (but not to bone, lung, brain and other internal organs).
Read more
Luxturna is an adeno-associated virus vector-based gene therapy indicated for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy. Patients must have viable retinal cells as determined by the treating physician(s).
Read more
Kymriah is indicated for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.
Read more
Made with
Drag and Drop Website Builder
SHARE